E. Januszewicz

ALTERED TRANSCRIPTION OF AN ONCOGENE IN CHRONIC MYELOID LEUKAEMIA

Eli Canaani, D. Steiner-Saltz, E Aghai et al. · The Lancet · 1984 · 154 citations

Hematological Malignancy, Chromatin, Transcriptional Regulation +7

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma

Chan Y. Cheah, Kirsten Herbert, Kacey O’Rourke et al. · British Journal of Cancer · 2014 · 129 citations · Full text

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy

Dennis Carney, David Westerman, Constantine S. Tam et al. · Leukemia · 2010 · 105 citations

Hematological Malignancy, Fludarabine Combination Chemotherapy, Medicine +10

Inhibition by retinoic acid of myeloid progenitors in chronic myeloid leukemia and myeloproliferative disease: increased sensitivity in blastic phase of chronic myeloid leukemia

E. Januszewicz, Esther Rabizadah, Zipora Maimon et al. · Pathology · 1988 · 96 citations

Hematological Malignancy, Increased Sensitivity, Chronic Myeloid Leukemia +8

Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non‐hodgkin lymphoma

Constantine S. Tam, Max Wolf, H. Miles Prince et al. · Cancer · 2006 · 94 citations